Use of central cannabinoid receptor antagonist for preparing medicines
AssigneeSanofi-Synthelabo
InventorsBernard Bourrie, Pierre Casellas
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a central cannabinoid receptor antagonist for the preparation of medicinal products that are useful in treating and preventing neuroinflammatory pathologies.
Claims16
A method for treating a neuroinflammatory pathology which comprises administering to a patient in need of said treatment an effective amount of N-piperidino-5-(4-chlorophenyl)- 1 -(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide or a pharmaceutically acceptable salt or solvate thereof.
A method for treating a neuroinflammatory pathology which comprises administering to a patient in need of said treatment an effective amount of N-piperidino-5-(4-chlorophenyl)- 1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide.
Dependencies are inferred from the claim text.